Andrea Colombo, Dario Carbonaro, Mingzi Zhang, Chi Shen, Ankush Kapoor, Nigel Jepson, Claudio Chiastra, Susann Beier
9 min
Abstract
Background Double Kissing (DK) Crush is a two-stent technique for complex coronary bifurcation lesions, yet the biomechanical influence of plaque on its performance remains poorly understood. This study developed a computational biomechanical model of the DK-Crush procedure to quantify how plaque presence and composition affect procedural outcomes and the performance of Xience Sierra and Orsiro stents. Methods A population-representative coronary bifurcation was modelled with no plaque, lipid plaque, and fibrous plaque. The complete DK-Crush sequence was simulated using finite element analysis for both stent platforms. Mechanical outcomes included arterial wall stress, malapposition, side branch ostium clearance, and residual stenosis. Post-deployment hemodynamics was assessed using pulsatile computational fluid dynamics, quantifying high shear rate volume and lumen area exposed to low time-averaged endothelial shear stress (TAESS). Results Plaque presence and stiffness reduced lumen restoration, increased arterial wall stress, led to larger high shear rate regions and, for fibrous plaque, increased exposure to low TAESS. Malapposition and ostial clearance depended mainly on stent design. Plaque also altered the relative performance of the two platforms, revealing differences not observed in plaque-free models. Conclusions Plaque characteristics substantially affect DK-Crush biomechanics and modify stent behaviour. Incorporating plaque is therefore essential for realistic computational evaluation of bifurcation stenting.
Alex: So it's like a virtual wind tunnel for artery surgery—predicting squeezes and stresses without touching a real patient.
Sam: Right. With fibrous plaque—the tougher kind—these issues worsened because it resists squishing flat, unlike softer lipid plaque.
Alex: Wait, and blood flow? Does the plaque mess that up too, even after everything's expanded?
Sam: Yes—they followed up FEA with another simulation for blood flow. Imagine pumping virtual blood through the final stented shape under a heartbeat-like pulse, tracking speeds and pressures along the walls. This is known as *computational fluid dynamics*, or CFD. The paper shows plaque-stiffened setups expand these risky flow areas, especially with fibrous types, and that's where stent differences like Xience Sierra versus Orsiro emerge—only visible when plaque's factored in.
Alex: Huh. So the real test of stents isn't clean tubes, but how they handle plaque's pushback on both structure and flow.
Sam: Precisely. This reveals plaque as the main driver, suggesting device picks matter less without it.
Alex: Okay, but let's dig into that blood flow part. You mentioned high shear and low stress areas—what exactly do those mean for risks like clots or re-narrowing?
Sam: Blood flow through narrow or uneven spots after stenting speeds up, making layers of blood slide past each other rapidly—like cars squeezing through a tight tunnel, bumping and stirring up particles that can start clots. The study found this rose substantially with plaque, especially the fibrous kind due to leftover narrowing. They also tracked the average rubbing force from blood on artery walls over a heartbeat cycle; spots with too little force let walls thicken and re-narrow.
Alex: So plaque doesn't just stiffen things mechanically—it creates flow trouble spots by resisting full expansion.
Sam: Precisely. Fibrous plaque left more high-shear volume because it yields less under balloon pressure, distorting the final shape more than softer lipid or no plaque. Stent differences, like thinner struts on Orsiro, only mattered here for slightly worse malapposition and stenosis, flipping clean-model predictions.
Alex: Huh... meaning doctors might prioritize plaque prep over stent type in tough cases.
Sam: The paper suggests that, yes—a notable insight since plaque drove outcomes across metrics, with hemodynamics confirming mechanical flaws lead directly to thrombogenic and restenosis risks. This underscores why full-sequence modeling with realistic plaque is key for reliable predictions.
Alex: So plaque not only worsens the mechanical results, but it changes how the two stents compare—like which one holds up better under real pressure.
Sam: That's a key shift. Without plaque, the stents perform similarly across measures like wall stress or gaps between stent and artery. But add plaque, especially the stiff fibrous kind, and differences emerge: Xience Sierra creates less leftover narrowing and better wall contact than Orsiro, because its thicker struts push harder against the resisting plaque. Stiffer plaque bounces back more, leaving uneven spots that thinner struts can't overcome as well.
Alex: Okay, so the plaque reveals the stents' true strengths—like testing tires on rough gravel instead of smooth pavement.
Sam: Precisely. That poor contact then feeds into blood flow problems: narrow spots speed up the blood, creating zones where it rubs the walls too harshly, stirring particles that can form clots.
Alex: Wait—so for doctors, ignoring plaque might pick the *wrong* stent based on lab tests alone?
Sam: The paper suggests exactly that. Plaque dominates metrics like narrowing and stress, while stent traits shine through only then. This provides a clear mechanistic reason why real procedures vary: disease stiffness, not just device, sets the risks for clots or re-thickening.
Alex: So overall, plaque isn't just a background detail—it's reshaping how we think about stent success from mechanics right through to blood flow risks.
Sam: Precisely. The study shows plaque characteristics drive key outcomes like leftover narrowing, wall stresses, and flow trouble spots far more than the choice between these two stents. This means plaque burden often outweighs device differences for things that matter clinically, like clot or re-narrowing risks—interactions that clean models completely miss.
Alex: That flips the script on planning, then. But what does this mean for how researchers build these models going forward?
Sam: Models without plaque underestimate the stresses on arteries and overestimate how well flow gets fixed after stenting. Patient differences in plaque shape, thickness, and makeup make it tough for any one simplified setup to cover everything, so for real predictions—like picking stents or techniques to cut re-narrowing or clots—scans of actual plaque properties become essential. Still, plaque-free versions have a role: they're quicker and let teams screen device tweaks or procedure changes without the mess of disease variety.
Alex: Okay, so a mix—simple for broad tests, detailed for patient-specific cases. Makes sense for balancing speed and accuracy.
Sam: Yes, each fits different needs: ideal shapes spot stent or step differences reliably and cheaply, while plaque-inclusive ones give the detail for complex real-world questions. But the paper notes limits worth keeping in mind—this used just one plaque shape, varying only stiffness, skipping steps like pre-stretching soft plaque or scoring tough ones before stenting, which doctors do to ease expansion.
Alex: Right, and no calcification or artery flexing in the flow sims either?
Sam: Correct—the flow tests assumed stiff walls without heartbeats or long-term changes like healing or thickening. It stuck to one technique and two stents, so trends might shift with others. These choices kept comparisons clean but mean broader variety needs more work for full clinical match.
Alex: Fair points—they lay out a solid first step without overclaiming. So patient-tailored plaque sims could really guide better choices down the line.
Sam: The paper positions this as the first full biomechanical look at DK-Crush with plaque, stressing its role in outcomes and how it reveals stent interactions hidden otherwise. It pushes for more lesion detail in models to better predict real procedure results. A meaningful nudge toward reliable tools for tough cases.
Alex: That's a clear takeaway—plaque as the key variable we can't ignore. Thanks, Sam, for breaking it down so thoroughly. Thanks for listening to ResearchPod.